Cue Biopharma CUE
NASDAQ CUE
$18.95 +1.91 (+11.21%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Other financing activities (2022)

Updated

Cue Biopharma (CUE) recorded Other financing activities of -$1,000 in Q4 2022.

Analysis

Cue Biopharma (CUE) Other financing activities (2022) Analysis & Trends

For FY2022, Cue Biopharma reported Other financing activities of $141,000.

  • Across earlier years, Other financing activities came in at -$787,272 in FY2018.
  • The Q4 2022 figure is the lowest quarterly Other financing activities since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Cue Biopharma 121.14 Mn 30.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1,000.00
Mar 31, 2022 -142,000.00
API Access

Cue Biopharma Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CUE&period=max&api_key=YOUR_API_KEY